GH1 and Prader-Willi syndrome: There was no significant impact of growth hormone therapy (GHT) found on insulin/HOMA‐IR values within nutritional phases in PWS when comparing those on GHT versus those who were not on GHT, however this may be due to the relatively small number of participants with PWS who were not on GHT.